NIT Rourkela develops novel bio-ink for 3D bioprinting and tissue engineering
The innovation is particularly suited for bone and cartilage repair
The innovation is particularly suited for bone and cartilage repair
The dispute stems from an earlier circular by Zuventus allegedly accusing Zorvia of market sabotage
The long-term exposure to fine particulate matter (PM2.5) increases overall cancer risk by 11%
The company said it is supporting the ongoing investigation and reiterated its commitment to patient safety.
The drug is designed to provide temporary relief from cough caused by throat and bronchial irritation
Genome editing holds extraordinary promise for treating previously incurable genetic diseases
ENFLONSIA is a long-acting monoclonal antibody designed to shield infants through a typical five-month RSV season with a single, fixed dose
Subscribe To Our Newsletter & Stay Updated